Drosophila melanogaster has been used as a model system in biological studies for a long time, and those studies have contributed to elucidating the principal mechanisms of life and aging. The notable advantages of Drosophila as a model system such as their low maintenance cost, high reproductive rate, and short generation time and lifespan make the flies a promising investigative platform for primary small-molecule screening of anti-aging drugs. In this review, we summarize and review the benefits of Drosophila as a model system for use in the study of pharmacological anti-aging interventions and describe the previously reported longevity effects of pharmacological interventions in Drosophila.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: